Y. Modigliani et al., REGULATORY T-CELLS IN THYMIC EPITHELIUM-INDUCED TOLERANCE .1. SUPPRESSION OF MATURE PERIPHERAL NONTOLERANT T-CELLS, European Journal of Immunology, 25(9), 1995, pp. 2563-2571
Athymic mice grafted at birth with allogeneic thymic epithelium (TE) d
isplay life-long tolerance to tissue grafts of the TE donor strain, in
spite of harboring peripheral T cells capable of rejecting those graf
ts. Tolerance is maintained in these chimeras by TE-specific regulator
y CD4 T cells. We presently address the quantification and the mechani
sms of this dominant tolerance process. C57BL/6 mice containing variab
ie but-defined numbers of peripheral, resident T cells received cell t
ransfers of graded numbers of peripheral T cells from B6(BALB E10) chi
meras (C57BL/6 nude mice grafted with TE from 10-day-old BALB/c embryo
s), resulting in a series of animals containing a wide range of donor
(tolerant) versus host (non-tolerant)T cell chimerism. Increasing the
relative repre sentation of donor T cells results in a progressive del
ay in the rejection of BALB/c skin grafts, life-long tolerance being a
chieved at a ratio of tolerant and non-tolerant T cell populations of
1. In recipients displaying full tolerance, graft-reactive non-toleran
t T cells were not deleted, anergized or committed to noninflammatory
functions. Thus, sorted host T cells from tolerant recipients readily
rejected BALB/c skin grafts upon transfer to immunodeficient animals.
Finally, measurements of ''helper'' and inflammatory activities, as we
ll as interleukin-4 and interferon-gamma production, failed to discrim
inate between T cell populations from tolerant and non-tolerant animal
s after specific in vitvo stimulation. We conclude that: (a) TE-select
ed regulatory T cells can suppress, in a quantitative manner, in vivo
T cell responses against major and minor histocompatibility antigens e
xpressed by the TE and, (b) this suppressive activity neither inactiva
tes mature non-tolerant T cells, nor does it seem to drive their diffe
rentiation along noninflammatory pathways.